Coronavirus Disease 2019 Case Surveillance - United States, January 22-May 30, 2020
- PMID: 32555134
- PMCID: PMC7302472
- DOI: 10.15585/mmwr.mm6924e2
Coronavirus Disease 2019 Case Surveillance - United States, January 22-May 30, 2020
Abstract
The coronavirus disease 2019 (COVID-19) pandemic resulted in 5,817,385 reported cases and 362,705 deaths worldwide through May, 30, 2020,† including 1,761,503 aggregated reported cases and 103,700 deaths in the United States.§ Previous analyses during February-early April 2020 indicated that age ≥65 years and underlying health conditions were associated with a higher risk for severe outcomes, which were less common among children aged <18 years (1-3). This report describes demographic characteristics, underlying health conditions, symptoms, and outcomes among 1,320,488 laboratory-confirmed COVID-19 cases individually reported to CDC during January 22-May 30, 2020. Cumulative incidence, 403.6 cases per 100,000 persons,¶ was similar among males (401.1) and females (406.0) and highest among persons aged ≥80 years (902.0). Among 599,636 (45%) cases with known information, 33% of persons were Hispanic or Latino of any race (Hispanic), 22% were non-Hispanic black (black), and 1.3% were non-Hispanic American Indian or Alaska Native (AI/AN). Among 287,320 (22%) cases with sufficient data on underlying health conditions, the most common were cardiovascular disease (32%), diabetes (30%), and chronic lung disease (18%). Overall, 184,673 (14%) patients were hospitalized, 29,837 (2%) were admitted to an intensive care unit (ICU), and 71,116 (5%) died. Hospitalizations were six times higher among patients with a reported underlying condition (45.4%) than those without reported underlying conditions (7.6%). Deaths were 12 times higher among patients with reported underlying conditions (19.5%) compared with those without reported underlying conditions (1.6%). The COVID-19 pandemic continues to be severe, particularly in certain population groups. These preliminary findings underscore the need to build on current efforts to collect and analyze case data, especially among those with underlying health conditions. These data are used to monitor trends in COVID-19 illness, identify and respond to localized incidence increase, and inform policies and practices designed to reduce transmission in the United States.
Conflict of interest statement
All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
Figures
Similar articles
-
COVID-19 Among American Indian and Alaska Native Persons - 23 States, January 31-July 3, 2020.MMWR Morb Mortal Wkly Rep. 2020 Aug 28;69(34):1166-1169. doi: 10.15585/mmwr.mm6934e1. MMWR Morb Mortal Wkly Rep. 2020. PMID: 32853193 Free PMC article.
-
Update: Characteristics of Health Care Personnel with COVID-19 - United States, February 12-July 16, 2020.MMWR Morb Mortal Wkly Rep. 2020 Sep 25;69(38):1364-1368. doi: 10.15585/mmwr.mm6938a3. MMWR Morb Mortal Wkly Rep. 2020. PMID: 32970661 Free PMC article.
-
Race/Ethnicity, Underlying Medical Conditions, Homelessness, and Hospitalization Status of Adult Patients with COVID-19 at an Urban Safety-Net Medical Center - Boston, Massachusetts, 2020.MMWR Morb Mortal Wkly Rep. 2020 Jul 10;69(27):864-869. doi: 10.15585/mmwr.mm6927a3. MMWR Morb Mortal Wkly Rep. 2020. PMID: 32644981 Free PMC article.
-
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020.MMWR Morb Mortal Wkly Rep. 2020 Apr 3;69(13):382-386. doi: 10.15585/mmwr.mm6913e2. MMWR Morb Mortal Wkly Rep. 2020. PMID: 32240123 Free PMC article.
-
Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit.JAMA Netw Open. 2020 Jun 1;3(6):e2012270. doi: 10.1001/jamanetworkopen.2020.12270. JAMA Netw Open. 2020. PMID: 32543702 Free PMC article. Review.
Cited by
-
COVID-19 Severity and Mortality in Two Pandemic Waves in Poland and Predictors of Poor Outcomes of SARS-CoV-2 Infection in Hospitalized Young Adults.Viruses. 2022 Jul 31;14(8):1700. doi: 10.3390/v14081700. Viruses. 2022. PMID: 36016322 Free PMC article.
-
Assessment of Tocilizumab (Humanized Monoclonal Antibody) for Therapeutic Efficacy and Clinical Safety in Patients with Coronavirus Disease (COVID-19).Medicina (Kaunas). 2022 Aug 10;58(8):1076. doi: 10.3390/medicina58081076. Medicina (Kaunas). 2022. PMID: 36013543 Free PMC article.
-
Burden of Food Insecurity and Mental Health Symptoms among Adults with Cardiometabolic Conditions during the COVID-19 Pandemic.Int J Environ Res Public Health. 2022 Aug 15;19(16):10077. doi: 10.3390/ijerph191610077. Int J Environ Res Public Health. 2022. PMID: 36011710 Free PMC article.
-
The Low Expression of Fc-Gamma Receptor III (CD16) and High Expression of Fc-Gamma Receptor I (CD64) on Neutrophil Granulocytes Mark Severe COVID-19 Pneumonia.Diagnostics (Basel). 2022 Aug 19;12(8):2010. doi: 10.3390/diagnostics12082010. Diagnostics (Basel). 2022. PMID: 36010361 Free PMC article.
-
Reviewing fair subject selection considerations for the unique case of post sequelae COVID-19 translational studies.J Clin Transl Sci. 2022 Jul 7;6(1):e91. doi: 10.1017/cts.2022.425. eCollection 2022. J Clin Transl Sci. 2022. PMID: 36003210 Free PMC article. Review.
References
-
- Chow N, Fleming-Dutra K, Gierke R, et al.; CDC COVID-19 Response Team. Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019—United States, February 12–March 28, 2020. MMWR Morb Mortal Wkly Rep 2020;69:382–6. 10.15585/mmwr.mm6913e2 - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
